临床研究
根治性前列腺切除术患者的一线治疗初始PSA > 20 ng / mL
|
| 参数 |
A组() |
B组() |
价值 |
|
| 患者年龄(年)±SD |
|
|
0.760 |
| 意思是PSA (ng / mL)±SD |
|
|
< 0.001 |
| 临床阶段(/ %)* |
|
|
|
| cT1 |
32 (24.4%) |
3 (4.1%) |
< 0.001 |
| cT2 |
91例(69.5%) |
43 (58.1%) |
0.101 |
| cT3-T4 |
8 (6.1%) |
28 (37.8%) |
< 0.001 |
| 格里森评分(/ %) |
|
|
|
| < 7 |
52 (39.7%) |
13 (17.6%) |
0.001 |
| = 7 |
55 (42.0%) |
28 (37.8%) |
0.557 |
| > 7 |
24 (18.3%) |
33 (44.6%) |
< 0.001 |
| 病理阶段(/ %)* |
|
|
|
| pT2 |
89例(67.9%) |
24 (32.4%) |
< 0.001 |
| pT3 |
37 (28.2%) |
42 (56.8%) |
< 0.001 |
| pT4 |
5 (3.8%) |
8 (10.8%) |
0.049 |
| 囊外的扩展(/ %) |
42 (32.1%) |
50 (67.6%) |
< 0.001 |
| 精囊入侵(/ %) |
35 (26.7%) |
45 (60.8%) |
< 0.001 |
| 淋巴结累及(/ %) |
19 (14.5%) |
35 (47.3%) |
< 0.001 |
| 积极的外科利润(/ %) |
20 (15.3%) |
31 (41.9%) |
< 0.001 |
|
|
*基于TNM分类,v . 2009。
|
